-
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
NCT05321368 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore, Denton
-
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
NCT07218029 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore
-
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
NCT06742723 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Bethesda
-
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
NCT07610278 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· Maryland: Ft. Washington, Lanham
-
Adaptive Optics Retinal Imaging
NCT05370287 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 21 Years and older ·
Sex: All (male and female)
· Maryland: Silver Spring
-
Addressing Hypertension Care in Africa Program
NCT06986590 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 70 Years ·
Sex: All (male and female)
· Maryland: Baltimore
-
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore
-
Childhood-Onset Essential Hypertension Natural History Study
NCT06778239 ·
Phase: Not specified ·
Ages: 2 Years to 99 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
Clarifying the Optimal Application of SLT Therapy Trial
NCT04967989 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore
-
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
NCT06402968 ·
Phase: Not specified ·
Ages: 18 Years to 100 Years ·
Sex: All (male and female)
· Maryland: Frederick
-
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
NCT03374215 ·
Phase: Not specified ·
Ages: 7 Years to 70 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT06388421 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore
-
Diabetes and Heart Disease Risk in Blacks
NCT00001853 ·
Phase: Not specified ·
Ages: 18 Years to 70 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma
NCT07147647 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Elkridge
-
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore, Olney, Oxon Hill, Salisbury
-
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
NCT07613099 ·
Phase: Phase 3 ·
Ages: 18 Years to 100 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
NCT05924477 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore
-
Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes
NCT06921356 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
NCT06299436 ·
Phase: Not specified ·
Ages: 18 Years to 90 Years ·
Sex: All (male and female)
· Maryland: Baltimore
-
Hydrus® Microstent New Enrollment Post-Approval Study
NCT04553523 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 45 Years and older ·
Sex: All (male and female)
· Maryland: Rockville
-
Imaging the Pathogenesis of Cerebral Small Vessel Disease
NCT05703386 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore
-
Implementation of a Beauty Salon-Based Strategy for Blood Pressure Management Among Women
NCT07042386 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 79 Years ·
Sex: Female
· Maryland: Baltimore
-
Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure
NCT07075588 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 21 Years to 70 Years ·
Sex: All (male and female)
· Maryland: Baltimore, Gaithersburg
-
Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
NCT07247058 ·
Phase: Phase 4 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore
-
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
NCT03206060 ·
Phase: Phase 2 ·
Ages: 18 Years to 100 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
NCT04401982 ·
Phase: Phase 4 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore, Columbia, Silver Spring
-
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
NCT01730092 ·
Phase: Not specified ·
Ages: 18 Years to 100 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
Natural History of Noncirrhotic Portal Hypertension
NCT02417740 ·
Phase: Not specified ·
Ages: 12 Years to 100 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
Natural History of Sickle Cell Disease
NCT00081523 ·
Phase: Not specified ·
Ages: 2 Years to 90 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
Optic Nerve Head Strain in Non-glaucoma Subjects
NCT07425535 ·
Phase: Early Phase 1 ·
Ages: 30 Years to 90 Years ·
Sex: All (male and female)
· Maryland: Baltimore
-
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
NCT04505618 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 99 Years ·
Sex: All (male and female)
· Maryland: Baltimore
-
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
NCT05286814 ·
Phase: Phase 2 ·
Ages: 18 Years to 120 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
NCT02249923 ·
Phase: Not specified ·
Ages: 1 Day to 21 Years ·
Sex: All (male and female)
· Maryland: Baltimore
-
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
NCT04278404 ·
Phase: Not specified ·
Ages: 0 Years to 20 Years ·
Sex: All (male and female)
· Maryland: Baltimore
-
Pulmonary Hypertension Association Registry
NCT04071327 ·
Phase: Not specified ·
Ages: 0 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore
-
Retinal Blood Flow and Autoregulation
NCT05344274 ·
Phase: Phase 4 ·
Ages: 18 Years to 88 Years ·
Sex: All (male and female)
· Maryland: Baltimore, Silver Spring
-
Spironolactone for Pulmonary Arterial Hypertension
NCT01712620 ·
Phase: Phase 2 ·
Ages: 18 Years to 100 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy
NCT06993597 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore
-
Study of Intravenous ZMA001 in Healthy Subjects
NCT05967299 ·
Phase: Phase 1 ·
Ages: 18 Years to 60 Years ·
Sex: All (male and female)
· Maryland: Bethesda
-
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
NCT07181109 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Maryland: Baltimore, Beltsville, Bowie, Lanham